Kite Pharma, Inc.
Aug 5, 2015

Kite Pharma to Present at the Canaccord Genuity 35th Annual Growth Conference

SANTA MONICA, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will present a company overview at the Canaccord Genuity 35th Annual Growth Conference on August 12, 2015 at 1:30pm Eastern Time. The conference will be held in Boston, MA.

The presentation will be available through the Calendar of Events section of Kite's website at ir.kitepharma.com

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com.

CONTACT: Kite Pharma

         Cynthia M. Butitta

         Chief Financial Officer and Chief Operating Officer

         310-824-9999



         For Media: Justin Jackson

         For Investor Inquiries: Lisa Burns and Carol Werther

         Burns McClellan

         212-213-0006

         jjackson@burnsmc.com

         lburns@burnsmc.com

         cwerther@burnsmc.com

Kite Pharma, Inc. logo

Source: Kite Pharma, Inc.

News Provided by Acquire Media